Ailar Nakhlband, Jaleh Barar*
|
Bryson C. Lochte, Sean A Guillory, Craig A. H. Richard*, William M. Kelley
|
Original Research
COVID-19
Khalil Ansarin  , Ramin Tolouian, Mohammadreza Ardalan*  , Ali Taghizadieh, Mojtaba Varshochi, Soheil Teimouri, Tahere Vaezi, Hamed Valizadeh, Parviz Saleh, Saeid Safiri  , Kenneth R. Chapman
Based on a randomized clinical trial, bromhexine is proposed as a potential therapeutic option in COVID-19. A total of 78 patients with similar demographic and disease characteristics were treated with results showing a significant reduction in ICU admissions.
|
|
Farhad Shokraneh, Roghayeh Ilghami, Rasoul Masoomi, Alireza Amanollahi*
|
Morteza Mahmoudi, Mingming Zhao, Yuka Matsuura, Sophie Laurent, Phillip C. Yang, Daniel Bernstein, Pilar Ruiz-Lozano*, Vahid Serpooshan*
|
Ali Nokhodchi*, Shaista Raja, Pryia Patel, Kofi Asare-Addo
|
Jaleh Barar  , Mohammad A. Rafi, Mohammad M. Pourseif, Yadollah Omidi*
|
Aliasghar Hamidi, Simin Sharifi, Soodabeh Davara, Saeed Ghasemi, Yadollah Omidi  , Mohammad-Reza Rashidi*
|
Yalda RahbarSaadat, Nazli Saeidi, Sepideh Zununi Vahed, Abolfazl Barzegari*, Jaleh Barar
|